The Clinical Development of Taldefgrobep Alfa: an Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.
NEUROLOGY AND THERAPY(2024)
关键词
Clinical trial,Duchenne muscular dystrophy,Taldefgrobep alfa,Neuromuscular disorder,Myostatin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要